The average cost of measles cases and adverse events following vaccination in industrialised countries

Carabin, Hélène; Edmunds, W. John; Kou, Ulla; Van den Hof, Susan; Van Hung Nguyen
January 2002
BMC Public Health;2002, Vol. 2 Issue 1, p22
Academic Journal
Background: Even though the annual incidence rate of measles has dramatically decreased in industrialised countries since the implementation of universal immunisation programmes, cases continue to occur in countries where endemic measles transmission has been interrupted and in countries where adequate levels of immunisation coverage have not been maintained. The objective of this study is to develop a model to estimate the average cost per measles case and per adverse event following measles immunisation using the Netherlands (NL), the United Kingdom (UK) and Canada as examples. Methods: Parameter estimates were based on a review of the published literature. A decision tree was built to represent the complications associated with measles cases and adverse events following imminisation. Monte-Carlo Simulation techniques were used to account for uncertainty. Results: From the perspective of society, we estimated the average cost per measles case to be US$276, US$307 and US$254 for the NL, the UK and Canada, respectively, and the average cost of adverse events following immunisation per vaccinee to be US$1.43, US$1.93 and US$1.51 for the NL, UK and Canada, respectively. Conclusions: These average cost estimates could be combined with incidence estimates and costs of immunisation programmes to provide estimates of the cost of measles to industrialised countries. Such estimates could be used as a basis to estimate the potential economic gains of global measles eradication.


Related Articles

  • Paradigms and Prevention. Vogt, Thomas M. // American Journal of Public Health;Jun93, Vol. 83 Issue 6, p795 

    This article presents information on various issues related to public health in the U.S. Americans are puzzled by the inconsistency between the nation's enormous and uncontrollable health care expenditures and its undistinguished health statistics relative to other industrialized nation. The...

  • Cost of Measles Epidemics.  // Clinical Pediatrics;Nov1967, Vol. 6 Issue 11, special section p24A 

    Presents a table of estimates of the annual costs of measles epidemics in a community unprotected by immunization, as compared with the cost of a community-wide immunization program. Estimates that are based on one million population prior to the use of measles vaccines.

  • Measles control in developing and developed countries: the case for a two-dose policy. Tulchinsky, T. H.; Ginsberg, G. M.; Abed, Y.; Angeles, M. T.; Akukwe, C.; Bonn, J. // Bulletin of the World Health Organization;1993, Vol. 71 Issue 1, p93 

    Despite major reductions in the incidence of measles and its complications, measles control with a single dose of the currently used Schwarz strain vaccine has failed to eradicate the disease in the developed countries. In developing countries an enormous toll of measles deaths and disability...

  • Progress toward Measles Eradication in the Region of the Americas. de Quadros, Ciro A.; Izurieta, Héctor; Carrasco, Peter; Brana, Monica; Tambini, Gina // Journal of Infectious Diseases;5/15/2003 Supplement, Vol. 187, pS102 

    Discusses progress in total measles eradication in Latin American countries. Implementation of catch-up vaccination campaigns by the Pan American Health Organization; Measles vaccination coverage in 2000 and 2001; Factors responsible for the achievement of zero indigenous measles transmission...

  • The public health implications of secondary measles vaccine failure. Ramsay, Mary; Brown, Kevin // Journal of Primary Health Care;Jun2013, Vol. 5 Issue 2, p92 

    The authors explore the implications of secondary measles vaccine failure for public health. They cite the difficulty of studying secondary measles vaccine failure, which is known to occur in around 5% of those vaccinated. They discuss the findings of a study that compared disease severity in...

  • Impact of Nationwide Measles Vaccination Campaign among Children Aged 9 Months to 14 Years, Zimbabwe, 1998--2001. Munyoro, M.N.; Kufa, E.; Biellik, R.; Pazvakavambwa, I.e.; Cairns, K.L. // Journal of Infectious Diseases;5/15/2003 Supplement, Vol. 187, pS91 

    Determines the impact of nationwide measles vaccination campaigns conducted in Zimbabwe among children aged 9 months to 14 years in 1998-2001. Interruption of indigenous measles transmission; Absence of impact of the high prevalence of HIV seropositivity on vaccination-induced measles control.

  • Measles Eradication in the Americas: Experience in Haiti. Venczel, Linda; Dobbins, James; André, Jean; Laender, Fernando; Izurieta, Héctor; Delorme, Patrick; Voltaire, Henri-Claude // Journal of Infectious Diseases;5/15/2003 Supplement, Vol. 187, pS127 

    Describes different strategies for mass immunization that were employed to eradicate measles in Haiti. Vaccination campaigns that used fixed posts; Door-to-door vaccination; Critical factors in the success of campaigns.

  • Nationwide Measles Vaccination Campaign for Children -- Afghanistan, 2002.  // MMWR: Morbidity & Mortality Weekly Report;4/25/2003, Vol. 52 Issue 16, p363 

    Describes the nationwide measles vaccination campaign implemented by the interim government of Afghanistan in 2002. Routine measles vaccination coverage from 1998 to 2001; Model for the measles vaccination campaign; Number of vaccination sites and mobile clinics established for the vaccination...

  • Ethics briefings. English, Veronica; Hamm, Danielle; Harrison, Caroline; Sheather, Julian; Sommerville, Ann // Journal of Medical Ethics;Feb2007, Vol. 33 Issue 2, p123 

    This article presents briefs on medical ethics. South Dakota people voted against abortion ban on November 7, 2006. The European Commission licensed a vaccine against cervical cancer in October 2006. The United Kingdom Prime Minister asked the public the take more responsibility for their own...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics